Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
Clinical trial NCT00933231 · COMPLETED
Trial details
- NCT number
- NCT00933231
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-17
- Primary completion
- 2015-05-11
- Enrollment
- 281
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.